BlackRock Fund Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

BlackRock Fund Advisors’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1K	Buy	27 +5	+23%	+$159	﹤0.01%	4222
2016 Q3	$0	Buy	22 +2	+10%	+$55	﹤0.01%	4279
2016 Q2	$1K	Buy	+20	New	+$753	﹤0.01%	4308
2015 Q2	–	Sell	-318	Closed	-$43K	–	3915
2015 Q1	$43K	Sell	318 -22	-6%	-$3.6K	﹤0.01%	3709
2014 Q4	$61K	Buy	340 +24	+8%	+$4.27K	﹤0.01%	3660
2014 Q3	$76K	Sell	316 -23	-7%	-$7.68K	﹤0.01%	3672
2014 Q2	$148K	Buy	339 +10	+3%	+$4.61K	﹤0.01%	3568
2014 Q1	$151K	Buy	329 +40	+14%	+$20.8K	﹤0.01%	3526
2013 Q4	$139K	Buy	289 +12	+4%	+$5.87K	﹤0.01%	3523
2013 Q3	$133K	Buy	277 +22	+9%	+$10.5K	﹤0.01%	3503
2013 Q2	$120K	Buy	+255	New	+$116K	﹤0.01%	3484

Other funds holding IDXG

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BlackRock Fund Advisors's IDXG Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Interpace Biosciences, Inc. Common Stock (IDXG) stake by 23% in Q4 2016, buying an estimated $159 and bringing the position to 27 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #4222.

BlackRock Fund Advisors first reported a position in IDXG in Q2 2013 and has held it in 11 quarters since. The position peaked at $151K in Q1 2014. 14 funds tracked by Wall St. Rank hold IDXG as of Q4 2016.

BlackRock Fund Advisors held 27 shares of Interpace Biosciences, Inc. Common Stock worth $1K as of Q4 2016.
BlackRock Fund Advisors bought 5 Interpace Biosciences, Inc. Common Stock shares in Q4 2016, an estimated $159.
Interpace Biosciences, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4222 holding.
BlackRock Fund Advisors first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and has held it in 11 quarters since.
BlackRock Fund Advisors's Interpace Biosciences, Inc. Common Stock position peaked at $151K in Q1 2014.
14 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.